https://www.selleckchem.com/products/me-401.html
Nerve allografts offer many advantages in the reconstruction of peripheral nerve gaps they retain their native microstructure, contain pro-regenerative Schwann cells, are widely available, and avoid donor site morbidity. Unfortunately, clinical use of nerve allografts is limited by the need for systemic immunosuppression and its adverse effects. To eliminate the toxicity of the systemic immunosuppressant FK506, we developed a local FK506 drug delivery system (DDS) to provide drug release over 28days. The study objective was to investigat
Like
Comment
Share
